With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Legal 500, 2020
Chambers UK, 2020
Chambers Asia-Pacific, 2020
Chambers Europe, 2019
Finland’s Recovery and Resilience Plan was published on 26 May 2021 and it is envisaged to boost investment in emissions-reducing solutions, accelerate sustainable growth in the economy, and create long-term growth ...
Hungary plans to channel the HUF 2,511 billion (EUR 7 billion) it expects to receive in the frame of the Recovery and Resilience Facility (“RRF”) under the NextGenerationEU initiative to finance investments primarily in ...
Among the European Union (“EU”) Member States, Italy is by far the largest beneficiary of the NextGenerationEU (“NGEU”) package, which, with its 750 billion euros funds, constitutes the largest stimulus package ever ...
Bird & Bird announces the arrival of Frédéric Portal as Counsel in the IP team - European Patent Attorney and member of the Paris Bar, Frédéric is a recognized expert with more than 20 years of experience in two of ...
Bird & Bird LLP has advised Vitruvian Partners LLP, a European private equity firm and investor in healthcare service provider doctari GmbH, on its acquisition of three companies.
International law firm Bird & Bird today grows its Corporate practice with the hire of Nick O’Donnell as a partner in London.
There are no forthcoming events for this area. Please click on the button below to view past events.